Kmg Fiduciary Partners, LLC Biogen Inc. Transaction History

Kmg Fiduciary Partners, LLC

$1.14 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	SELL	$222.59 - $267.94 $85,919 - $103,424	-386 Reduced 25.73%	1,114 $288,000
Q3 2023 Oct 25, 2023	SELL	$253.3 - $285.89 $49,646 - $56,034	-196 Reduced 11.56%	1,500 $385,000
Q2 2023 Jul 14, 2023	SELL	$275.25 - $318.06 $172,306 - $199,105	-626 Reduced 26.96%	1,696 $483,000
Q1 2023 Apr 13, 2023	SELL	$256.56 - $292.34 $95,183 - $108,458	-371 Reduced 13.78%	2,322 $645,000
Q4 2022 Jan 12, 2023	SELL	$252.44 - $306.72 $65,886 - $80,053	-261 Reduced 8.84%	2,693 $0
Q3 2022 Oct 27, 2022	SELL	$194.69 - $268.46 $728,335 - $1 Million	-3,741 Reduced 55.88%	2,954 $789,000
Q2 2022 Jul 13, 2022	SELL	$187.54 - $223.02 $132,590 - $157,675	-707 Reduced 9.55%	6,695 $1.37 Million
Q1 2022 Apr 19, 2022	SELL	$193.77 - $244.14 $372,425 - $469,237	-1,922 Reduced 20.61%	7,402 $1.56 Million
Q4 2021 Jan 12, 2022	SELL	$223.92 - $287.77 $892,097 - $1.15 Million	-3,984 Reduced 29.94%	9,324 $2.24 Million
Q3 2021 Oct 12, 2021	SELL	$282.99 - $369.05 $291,196 - $379,752	-1,029 Reduced 7.18%	13,308 $3.77 Million
Q2 2021 Jul 20, 2021	SELL	$259.0 - $414.71 $38,332 - $61,377	-148 Reduced 1.02%	14,337 $4.96 Million
Q1 2021 Apr 08, 2021	BUY	$242.95 - $284.63 $35,956 - $42,125	148 Added 1.03%	14,485 $4.05 Million
Q4 2020 Jan 13, 2021	BUY	$236.26 - $355.63 $304,066 - $457,695	1,287 Added 9.86%	14,337 $3.53 Million
Q3 2020 Oct 13, 2020	BUY	$264.77 - $305.71 $281,715 - $325,275	1,064 Added 8.88%	13,050 $3.7 Million
Q2 2020 Jul 22, 2020	BUY	$258.66 - $342.55 $209,255 - $277,122	809 Added 7.24%	11,986 $3.21 Million
Q1 2020 Apr 29, 2020	BUY	$268.85 - $341.04 $115,605 - $146,647	430 Added 4.0%	11,177 $3.54 Million
Q4 2019 Jan 29, 2020	BUY	$220.06 - $304.07 $2,860 - $3,952	13 Added 0.12%	10,747 $3.19 Million
Q3 2019 Oct 15, 2019	SELL	$217.44 - $243.88 $43,488 - $48,776	-200 Reduced 1.83%	10,734 $2.5 Million
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $35,524 - $39,158	162 Added 1.5%	10,934 $2.56 Million
Q1 2019 Apr 16, 2019	SELL	$216.71 - $338.96 $336,550 - $526,404	-1,553 Reduced 12.6%	10,772 $2.55 Million
Q4 2018 Apr 15, 2019	BUY	$278.5 - $352.75 $3.43 Million - $4.35 Million	12,325 New	12,325 $3.71 Million

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kmg Fiduciary Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kmg Fiduciary Partners, LLC with notifications on news.

Account